DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
BankPosition in RDY — Dr Reddys Laboratories Ltd
CIK 1694217
FRANKFURT AM MAIN, 2M
Position in RDY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,540,000
-$76,000 QoQ
Shares Held
400,000
0.0% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RDY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main holds $52,318,865 across 12 Drug Manufacturers - Specialty & Generic names. RDY ranks #5 (10.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
502,931 | $15,148,281 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
107,796 | $14,201,045 | |
| 3 | ZTS |
Zoetis Inc.
|
55,580 | $6,570,110 | |
| 4 | BHC |
Bausch Health Companies Inc.
|
1,113,755 | $6,014,277 | |
| 5 | RDY |
Dr Reddys Laboratories Ltd
This page
|
400,000 | $5,540,000 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
52,809 | $2,729,697 | |
| 7 | ALKS |
Alkermes plc.
|
37,964 | $1,342,407 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
|
966 | $572,818 |
All Filings in RDY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,540,000 | 400,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,616,000 | 400,000 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $5,592,000 | 400,000 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $6,012,000 | 400,000 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,276,000 | 400,000 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $6,316,000 | 400,000 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $6,356,000 | 80,000 | Shares | Defined | 2026-05-04 | |
| 2024-06-30 | $6,095,200 | 80,000 | Shares | Defined | 2026-05-04 | |
| 2024-03-31 | $5,868,000 | 80,000 | Shares | Defined | 2026-05-04 | |
| 2023-12-31 | $9,000,938 | 129,361 | Shares | Defined | 2026-05-04 | |
| 2023-09-30 | $8,797,484 | 131,561 | Shares | Defined | 2026-05-04 | |
| 2023-06-30 | $10,152,442 | 160,869 | Shares | Defined | 2026-05-04 | |
| 2023-03-31 | $9,609,784 | 168,800 | Shares | Defined | 2024-05-17 | |
| 2022-12-31 | $9,770,400 | 188,800 | Shares | Defined | 2024-05-17 | |
| 2022-09-30 | $9,614,858 | 183,700 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,447,396 | 116,400 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $6,838,071 | 122,700 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $8,980,793 | 137,300 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $8,943,722 | 137,300 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $10,489,877 | 142,700 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $7,145,796 | 116,400 | Shares | Defined | 2026-05-04 | |
| 2020-12-31 | $7,513,966 | 105,400 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $6,636,024 | 95,400 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $5,057,154 | 95,400 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $3,928,142 | 97,400 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||